ZYMAXID is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Gatifloxacin.
Product ID | 0023-3615_4ec8c286-058d-40fa-a7b8-71324e7c230f |
NDC | 0023-3615 |
Product Type | Human Prescription Drug |
Proprietary Name | ZYMAXID |
Generic Name | Gatifloxacin |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2010-05-19 |
Marketing Category | NDA / NDA |
Application Number | NDA022548 |
Labeler Name | Allergan, Inc. |
Substance Name | GATIFLOXACIN |
Active Ingredient Strength | 5 mg/mL |
Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-05-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022548 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-05-19 |
Marketing Category | NDA |
Application Number | NDA022548 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-05-19 |
Marketing Category | NDA |
Application Number | NDA022548 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-05-19 |
Marketing End Date | 2012-09-05 |
Ingredient | Strength |
---|---|
GATIFLOXACIN | 5 mg/mL |
SPL SET ID: | 1160b16c-929a-4e85-9c0b-1d8c96a7678b |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0023-3615 | ZYMAXID | gatifloxacin |
0378-5431 | Gatifloxacin | gatifloxacin |
13668-526 | Gatifloxacin | Gatifloxacin |
50383-189 | Gatifloxacin | Gatifloxacin |
57297-435 | Gatifloxacin | Gatifloxacin |
60758-615 | gatifloxacin | gatifloxacin |
61314-672 | Gatifloxacin | gatifloxacin |
68180-435 | Gatifloxacin | Gatifloxacin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZYMAXID 77781640 3894801 Live/Registered |
Allergan, Inc. 2009-07-15 |
ZYMAXID 74266695 not registered Dead/Abandoned |
Johnson & Johnson-Merck Consumer Pharmaceuticals Company 1992-04-17 |